newsfilter
← Latest News
GlobeNewswire·

Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028

COPENHAGEN, Denmark, April 21, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND) today announced that it has called all $575.0 million aggregate principal amount of its outstanding 2.25% Convertible Senior